Company Profile

Associates of Cape Cod Inc (AKA: ACC)
Profile last edited on: 1/4/16      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1974
First Award
1983
Latest Award
1983
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

Falmouth Technology Park 124 Bernard E. Saint Jean Drive
East Falmouth, MA 02536
   (508) 540-3444
   info@acciusa.com
   www.acciusa.com
Location: Single
Congr. District: 09
County: Barnstable

Public Profile

Associates of Cape Cod, Inc. (ACC), is one of the world's largest manufacturers of products developed to detect and quantify gram-negative bacterial endotoxins and (1→3)-ß-D-glucans. The firm's products are used worldwide by leading pharmaceutical and medical device companies to ensure the safety of their parenteral drugs, biological products and medical devices. The firms is ISO 13485: 2012 & 2003 certified; laboratories are FDA Inspected and DEA Licensed and =Beacon Diagnostics ® laboratory is CLIA certified. located in East Falmouth, MA with offices in the UK and Germany. The firm was among the first to be licensed by the FDA to manufacture LAL for use as a quality control test for endotoxin detection in the pharmaceutical and medical device markets. A very early SBIR involved firm but with limited program participation, ACC as grown to have aninternational in endotoxin detection, with over 150 employees and a distribution network servicing 80 countri

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1983 1 NIH $50,000
Project Title: Endotoxin Neutralizing Capacity of Serum

Key People / Management

  Thomas Novitsky -- President

  Stanely Watson -- President

Company News

There are no news available.